Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Number of Votes Cast ForPHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024.
2024年6月26日，hql基金（"abrdn Life Sciences Investors"）宣佈股東年會（"會議"）的結果，會議於2024年6月25日舉行。
As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% of outstanding common stock were voted representing a quorum.
截至記錄日期2024年4月1日，hql基金擁有27,350,517股普通股，佔全部普通股的87.84%，代表法定人數的投票。
Shareholders approved the election of two Class B Trustees to the Board to serve until 2027 Annual Meeting by the following votes:
股東們通過了以下選票，批准了兩名B類董事會受託人當選爲董事會成員，任期至2027年年度股東大會：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
|
| Stephen Bird | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| Jeffrey Bailey | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
投票支持人數 |
投票支持百分比 |
投票反對/棄權人數 |
投票反對/棄權百分比 |
|
| 史蒂芬·伯德 | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| 傑弗裏·貝利 | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
Shareholders opposed a shareholder proposal regarding annual terms of trustees by the following votes:
股東們否決了有關董事年度任期的股東提案，以下爲反對票：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
Number of Votes |
Percentage |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
投票支持人數 |
投票支持百分比 |
投票反對/棄權人數 |
投票反對/棄權百分比 |
得票數 |
百分比 |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
In the United States, abrdn is the marketing name for the following affiliated, registered investment advisers: abrdn Inc., abrdn Investments Limited, abrdn Asia Limited, and abrdn ETFs Advisors LLC.
在美國，abrdn是以下注冊投資顧問的市場營銷名稱：abrdn Inc.，abrdn Investments Limited，abrdn Asia Limited和abrdn ETFs Advisors LLC。
Closed-end funds are traded on the secondary market through one of the stock exchanges. A Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that a Fund will achieve its investment objective. Past performance does not guarantee future results.
封閉式基金通過一家股票交易所在二級市場交易。基金的投資回報和本金價值將波動，因此投資者的股份可能比原始成本價值高或低。封閉式基金的股份可能高於（溢價）或低於（折價）基金組合的淨資產價值（NAV）。基金將達到其投資目標不能保證。過去的業績不代表未來的結果。
# # #
# # #
For More Information Contact:
abrdn U.S. Closed-End Funds
Investor Relations
800-522-5465
Investor.Relations@abrdn.com
欲知詳情，請聯繫：
abrdn美國封閉式基金
投資者關係
800-522-5465
Investor.Relations@abrdn.com
SOURCE: abrdn U.S. Closed-End Funds
來源：abrdn美國封閉式基金
譯文內容由第三人軟體翻譯。
